Tanasescu R, Frakich N, Chou I-J, et al. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023. doi:10.1007/s40120-023-00539-9.
Jagoda E, Marnetto D, Senevirathne G, et al. Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals. eLife. 2023;12. doi:10.7554/eLife.71235.